September 9, 2008 – Nucletron will introduce its latest innovation in image-guided adaptive brachytherapy for cervical cancer at the ESTRO 2008 conference in Gothenburg, Sweden Sept. 14-18 and one week later, at ASTRO 2008 in Boston, Sept. 21-25, 2008.
Nucletron and the General Hospital Vienna (AKH)/Medical University of Vienna (MUW) have extended their longstanding cooperation through a multi-tiered partnership to advance image-guided adaptive brachytherapy for gynecology and have developed a brand-new technology called Oncentra GYN.
Together with the Vienna Ring Applicator, Oncentra GYN provides a unique solution for image-guided adaptive brachytherapy combining the intracavitary and interstitial technique for tumors with unfavorable topography. Oncentra GYN supports fully the GEC-ESTRO recommendations for gynecologic brachytherapy as well as all clinical protocols.
“Oncentra GYN, in combination with the Vienna Ring Applicator, sets a new standard for intracavitary and interstitial applications,” said Jos Lamers, chief executive officer of Nucletron. “This revolutionary technology allows tumors to be effectively irradiated while minimizing damage to healthy organs in the pelvic region.”
“This solution allows the most precise method of applicator reconstruction, anatomy-based loading and anatomy-based optimization for daily clinical practice available yet,” said Professor Christian Kirisits, M.D., director of brachytherapy physics at AKH. “The new tools are based on the experiences with a long tradition of cervix cancer brachytherapy. Oncentra GYN covers all needs from simple manual adaptation of dose distributions, and inverse optimization adapted for each individual fraction, up to dynamic planning during the insertion of the applicator.”
By extending their partnership, Nucletron and AKH Vienna have set the stage for future innovations in the field of adaptive brachytherapy with the clear aim of further improving patient care.
For more information: www.nucletron.com